| Drug | Class/Mechanism | Clinical Use | Notes |
| Desmopressin | Antidiuretic Hormone Analog (V2 Selective) | Central Diabetes Insipidus, Nocturnal Enuresis | Also increases Von Willebrand Factor (useful for bleeding). |
| Vasopressin | Antidiuretic Hormone Analog (V1 and V2) | Diabetes Insipidus, Septic Shock | V1 causes vasoconstriction; V2 causes water reabsorption. |
| Thiazides | Paradoxical effect in Nephrogenic Diabetes Insipidus | Nephrogenic Diabetes Insipidus | Causes mild volume depletion, increasing proximal reabsorption of water. |
| Indomethacin | Nonsteroidal Anti-inflammatory Drug | Nephrogenic Diabetes Insipidus | Prostaglandins normally inhibit Antidiuretic Hormone; blocking them enhances Antidiuretic Hormone effect. |
| Drug Class | Prototype Drugs | Mechanism of Action | Clinical Use |
| Antimuscarinics (M3 Antagonists) | Oxybutynin, Tolterodine, Darifenacin, Solifenacin | Block M3 receptors on the detrusor muscle, decreasing bladder contraction. | Urge Incontinence (Overactive Bladder). |
| Beta-3-Agonists | Mirabegron | Activates Beta-3 receptors in the detrusor, leading to muscle relaxation and increased bladder capacity. | Urge Incontinence; often used if antimuscarinics are poorly tolerated. |
| Tricyclic Antidepressants | Imipramine | Has strong anticholinergic properties that relax the detrusor. | Historically used for Nocturnal Enuresis (bedwetting) in children. |
| Drug Class | Prototype Drugs | Mechanism of Action | Clinical Use |
| Cholinergic Agonists | Bethanechol | Activates M3 receptors on the detrusor muscle to stimulate contraction. | Neurogenic Ileus or Postoperative Urinary Retention. |
| Alpha-1-Blockers (Selective) | Tamsulosin, Alfuzosin | Block Alpha-1A receptors in the prostate and bladder neck, relaxing smooth muscle to improve flow. | Benign Prostatic Hyperplasia causing overflow issues. |
| Alpha-1-Blockers (Non-selective) | Terazosin, Doxazosin | Block Alpha-1 receptors in both the prostate and vascular smooth muscle. | Benign Prostatic Hyperplasia in patients who also have Hypertension. |
| 5-Alpha Reductase Inhibitors | Finasteride, Dutasteride | Inhibit the conversion of Testosterone to Dihydrotestosterone, shrinking the prostate over months. | Chronic Benign Prostatic Hyperplasia management to prevent urinary obstruction. |